| Calcineurin inhibitor nephrotoxicity M Naesens, DRJ Kuypers, M Sarwal Clinical Journal of the American Society of Nephrology 4 (2), 481-508, 2009 | 1646 | 2009 |
| The Banff 2017 Kidney Meeting Report: Revised diagnostic criteria for chronic active T cell–mediated rejection, antibody‐mediated rejection, and prospects for integrative … M Haas, A Loupy, C Lefaucheur, C Roufosse, D Glotz, D Seron, ... American Journal of Transplantation 18 (2), 293-307, 2018 | 1041 | 2018 |
| The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell–and antibody‐mediated rejection A Loupy, M Haas, C Roufosse, M Naesens, B Adam, M Afrouzian, ... American Journal of Transplantation 20 (9), 2318-2331, 2020 | 549 | 2020 |
| Analyses of the short-and long-term graft survival after kidney transplantation in Europe between 1986 and 2015 M Coemans, C Süsal, B Döhler, D Anglicheau, M Giral, O Bestard, ... Kidney international 94 (5), 964-973, 2018 | 269 | 2018 |
| CYP3A5 and CYP3A4 but not MDR1 Single‐nucleotide Polymorphisms Determine Long‐term Tacrolimus Disposition and Drug‐related Nephrotoxicity in Renal … DRJ Kuypers, H De Jonge, M Naesens, E Lerut, K Verbeke, ... Clinical pharmacology & therapeutics 82 (6), 711-725, 2007 | 266 | 2007 |
| Multidrug resistance protein 2 genetic polymorphisms influence mycophenolic acid exposure in renal allograft recipients M Naesens, DRJ Kuypers, K Verbeke, Y Vanrenterghem Transplantation 82 (8), 1074-1084, 2006 | 253 | 2006 |
| Prediction system for risk of allograft loss in patients receiving kidney transplants: international derivation and validation study A Loupy, O Aubert, BJ Orandi, M Naesens, Y Bouatou, M Raynaud, ... Bmj 366, 2019 | 250 | 2019 |
| A common rejection module (CRM) for acute rejection across multiple organs identifies novel therapeutics for organ transplantation P Khatri, S Roedder, N Kimura, K De Vusser, AA Morgan, Y Gong, ... Journal of Experimental Medicine 210 (11), 2205-2221, 2013 | 241 | 2013 |
| The impact of uridine diphosphate–glucuronosyltransferase 1A9 (UGT1A9) gene promoter region single‐nucleotide polymorphisms T—275A and C—2152T on … DRJ Kuypers, M Naesens, S Vermeire, Y Vanrenterghem Clinical Pharmacology & Therapeutics 78 (4), 351-361, 2005 | 237 | 2005 |
| Intrarenal resistive index after renal transplantation M Naesens, L Heylen, E Lerut, K Claes, L De Wever, F Claus, R Oyen, ... New England Journal of Medicine 369 (19), 1797-1806, 2013 | 235 | 2013 |
| A circulating antibody panel for pretransplant prediction of FSGS recurrence after kidney transplantation M Delville, TK Sigdel, C Wei, J Li, SC Hsieh, A Fornoni, GW Burke, ... Science translational medicine 6 (256), 256ra136-256ra136, 2014 | 225 | 2014 |
| Tertiary ‘hyperphosphatoninism’accentuates hypophosphatemia and suppresses calcitriol levels in renal transplant recipients P Evenepoel, M Naesens, K Claes, D Kuypers, Y Vanrenterghem American Journal of Transplantation 7 (5), 1193-1200, 2007 | 202 | 2007 |
| Bartter’s and Gitelman’s syndromes: from gene to clinic M Naesens, P Steels, R Verberckmoes, Y Vanrenterghem, D Kuypers Nephron Physiology 96 (3), p65-p78, 2004 | 196 | 2004 |
| New insights into the pharmacokinetics and pharmacodynamics of the calcineurin inhibitors and mycophenolic acid: possible consequences for therapeutic drug monitoring in solid … H de Jonge, M Naesens, DRJ Kuypers Therapeutic drug monitoring 31 (4), 416-435, 2009 | 189 | 2009 |
| Recovery of hyperphosphatoninism and renal phosphorus wasting one year after successful renal transplantation P Evenepoel, BKI Meijers, H de Jonge, M Naesens, B Bammens, K Claes, ... Clinical Journal of the American Society of Nephrology 3 (6), 1829-1836, 2008 | 184 | 2008 |
| The P450 Oxidoreductase *28 SNP is Associated with Low Initial Tacrolimus Exposure and Increased Dose Requirements in CYP3A5-Expressing Renal Recipients H De Jonge, C Metalidis, M Naesens, D Lambrechts, DRJ Kuypers Pharmacogenomics 12 (9), 1281-1291, 2011 | 177 | 2011 |
| Expression of complement components differs between kidney allografts from living and deceased donors M Naesens, L Li, L Ying, P Sansanwal, TK Sigdel, SC Hsieh, N Kambham, ... Journal of the American Society of Nephrology 20 (8), 1839-1851, 2009 | 174 | 2009 |
| Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts M Naesens, E Lerut, H de Jonge, B Van Damme, Y Vanrenterghem, ... Journal of the American Society of Nephrology 20 (11), 2468-2480, 2009 | 173 | 2009 |
| The histology of kidney transplant failure: a long-term follow-up study M Naesens, DRJ Kuypers, K De Vusser, P Evenepoel, K Claes, ... Transplantation 98 (4), 427-435, 2014 | 168 | 2014 |
| Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up MM Sarwal, RB Ettenger, V Dharnidharka, M Benfield, R Mathias, ... American Journal of Transplantation 12 (10), 2719-2729, 2012 | 156 | 2012 |
Evelyne LerutProfessor of Translational Cell & Tissue Research在 med.kuleuven.be 的电子邮件经过验证
